PE/Cyanine5.5 Anti-Human CD8a Antibody[OKT-8]

Introducing the PE/Cyanine5.5 Anti-Human CD8a Antibody [OKT-8], a highly specialized and meticulously crafted product designed to facilitate accurate identification and analysis of CD8a antigen expression in human samples. This antibody, conjugated with the exceptional PE/Cyanine5.5 fluorochrome, offers exceptional sensitivity and specificity, ensuring reliable and precise results in various research applications.

The PE/Cyanine5.5 Anti-Human CD8a Antibody [OKT-8] is meticulously developed using advanced techniques and stringent quality control measures. It exhibits exceptional binding affinity towards the CD8a antigen, a crucial cell surface glycoprotein expressed on cytotoxic T cells, natural killer cells, and a subset of dendritic cells. This antibody's specificity for CD8a enables researchers to accurately distinguish and quantify CD8a-positive cells within complex cellular populations.

With its PE/Cyanine5.5 fluorochrome conjugation, this antibody provides enhanced fluorescence intensity and minimal spectral overlap, ensuring optimal signal detection and minimal background noise. This feature enables researchers to achieve reliable and reproducible results, even in challenging experimental conditions.

The PE/Cyanine5.5 Anti-Human CD8a Antibody [OKT-8] is compatible with various experimental techniques, including flow cytometry, immunohistochemistry, and immunofluorescence. Its versatility allows for seamless integration into diverse research workflows, facilitating comprehensive investigations into CD8a expression patterns and cellular interactions.

Furthermore, this antibody is manufactured under strict quality control guidelines, ensuring batch-to-batch consistency and reliability. Each lot is rigorously tested to meet the highest standards of performance, guaranteeing consistent and reproducible results across experiments.

In summary, the PE/Cyanine5.5 Anti-Human CD8a Antibody [OKT-8] is a cutting-edge research tool that empowers scientists and researchers to delve deeper into the intricate world of CD8a antigen expression. With its exceptional sensitivity, specificity, and compatibility with various techniques, this antibody is an invaluable asset for elucidating the role of CD8a-positive cells in immunology, oncology, and beyond.